• Biotin-XX Tyramide Reagent for Cell-Surface Mapping

  2026-08-31

  Biotin-XX Tyramide Reagent combines HRP-driven signal amplification with membrane-restricted labeling for sensitive cell-surface imaging and proteome profiling. This guide translates the astrocyte–neuron surface-mapping strategy into practical workflows, controls, and troubleshooting decisions.

• Capsazepine for TRPV1 Pain Research

  2026-08-31

  Capsazepine is a practical pharmacological probe for separating TRPV1-dependent calcium signaling and nociception from broader inflammatory pathways. This workflow connects concentration-controlled channel assays with pain-model validation, TRPM8 selectivity checks, and exploratory apoptosis studies.

• 2-Deoxy-D-glucose and Lactylation in NSCLC

  2026-08-30

  2-Deoxy-D-glucose offers a practical way to interrogate how glycolytic metabolism may influence lactylation, senescence, and KRT19 biology in NSCLC. This article translates recent mechanistic findings into a rigorous assay strategy while distinguishing evidence from testable hypotheses.

• MG-132: From Proteostasis to Translational Insight

  2026-08-29

  MG-132, also known as Z-LLL-al, is more than a proteasome inhibitor: it is a time-controlled probe for connecting protein turnover with apoptosis, cell-cycle behavior, and oxidative stress. This thought-leadership perspective links MG-132 workflow design to new findings on the GhATL68b ubiquitin pathway in cotton fiber development while defining the limits of cross-domain translation.

• MLN2238 Proteasome β5 Inhibitor Workflows

  2026-08-28

  Build reproducible MLN2238 assays around selective chymotrypsin-like proteasome inhibition, direct target engagement, and downstream apoptosis or stress signaling. The workflow also translates ROS–JNK–CREB findings into practical assay choices for multiple myeloma, lymphoma, and proteostasis research.

• Abiraterone Acetate in 3D Prostate Models

  2026-08-28

  Abiraterone acetate is a CYP17 inhibitor whose activity can look very different in patient-derived three-dimensional prostate models. This article connects steroid biology, prodrug handling, spheroid quality control, and endpoint selection to improve prostate cancer research decisions.

• Okadaic acid: PP1/PP2A Workflow Guide

  2026-08-27

  Okadaic acid provides a controlled way to inhibit PP2A preferentially at low nanomolar exposure and to inhibit PP1 at higher exposure, supporting phosphorylation-dependent signaling and apoptosis studies. It is appropriate for defined biochemical or cell-based experiments with matched controls, but should not be treated as a broad phosphatase inhibitor or assigned a universal cell-treatment dose.

• Olsalazine Sodium Research Workflows

  2026-08-27

  Olsalazine Sodium supports reproducible inflammation, colorectal cancer, and xenobiotic-clearance experiments when its aqueous solubility and prodrug biology are handled deliberately. This guide connects tumor apoptosis induction and LTB4 chemotaxis assays with a recent mosquito transport study, providing practical setup, controls, and troubleshooting decisions.

• Topotecan (SKF104864) in Replication-Stress Research

  2026-08-26

  Topotecan (SKF104864) converts topoisomerase I activity into a controllable replication-stress challenge for tumor-cell, glioma, and DNA-repair assays. This workflow connects dose-response phenotyping with Dna2-dependent genome-maintenance studies while emphasizing practical controls, timing, and troubleshooting.

• BIRC2 and BIRC3 Regulation in Lung Epithelium

  2026-08-26

  The reference study distinguishes how inflammatory cytokines and glucocorticoids regulate the related inhibitor-of-apoptosis genes BIRC2 and BIRC3 in pulmonary epithelial models. Its comparison of cell lines with primary bronchial epithelium shows that BIRC3 is strongly inducible and glucocorticoid-responsive, whereas BIRC2 is comparatively constitutive, providing a framework for interpreting epithelial inflammatory and survival responses.

• Cy3-UTP for Fluorescent RNA Workflows

  2026-08-25

  Cy3-UTP enables direct fluorescent RNA labeling during in vitro transcription, supporting RNA imaging, binding assays, and sensitive detection workflows. This guide combines practical optimization steps with a careful comparison to CRISPR-based live-cell chromatin imaging.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-08-25

  Zhao and colleagues present a standardized whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic interventions and cytokine measurement. The workflow preserves the physiological complexity of blood while enabling cohort-scale analysis of how metabolic pathways selectively shape immune responses.

• TBK1, Microglial Pyroptosis, and Diabetic Neuropathy

  2026-08-24

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy by linking its activation in spinal microglia to NF-κB signaling, NLRP3 inflammasome activity, and pyroptosis. Their combination of genetic knockdown, pharmacological inhibition, behavioral testing, and tissue profiling provides a framework for studying neuroinflammation as a therapeutic axis in diabetic pain.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-24

  Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified concentration-dependent activity for established inhibitors and aminophylline, while finding no evidence of TOR inhibition for several tested compounds, including nebivolol, illustrating both the platform’s screening value and its assay-specific limitations.

• CFDA-SE for Cell Proliferation Tracking

  2026-08-23

  CFDA-SE, also called Carboxyfluorescein diacetate succinimidyl ester, is a cell-permeable fluorescent labeling reagent that converts intracellular esterase activity into a durable signal. Its generation-dependent fluorescence loss supports flow-cytometric analysis of lymphocyte, fibroblast, natural killer cell, and bacterial proliferation.

8172 records 9/545 page Previous Next First page 上5页 678910 下5页 Last page